Host: Rabbit
Target Protein: Integrin Alpha V + Beta 5
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 3685
Swiss Prot: P06756
Source: KLH conjugated synthetic peptide derived from human Integrin beta 5 and Integrin alpha V
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
ELISA(1:500-1000)
FCM(1:20-100)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
Predicted Molecular Weight: 88/121
Cross Reactive Species:
Human
Mouse
Predicted Cross Reactive Species: Rat
For research use only. Not intended for diagnostic or therapeutic use.
- Mondal, Goutam, Sugata Barui, and Arabinda Chaudhuri. "The relationship between the cyclic-RGDfK ligand and ??v??3 integrin receptor."iomaterials (2013).iiRead more>>
- Chen, Ming, et al. "Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma." Journal of the Neurological Sciences (2015).Read more>>
- Nande, Rounak Paramjeet, "Investigation Of Ultrasound Targeted Microbubbles As A Therapeutic Gene Delivery System For Prostate Cancer" (2015). Theses, Dissertations and Capstones. Paper 915.Read more>>
- Bian, Qin, et al. "Mechanosignaling activation of TGFβ maintains intervertebral disc homeostasis." Bone Research 5 (2017): 17008.Read more>>
- Tomohiro Yokotaet al. Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury. Cell. 2020 Aug 6;182(3):545-562.e23.Read more>>
- Yusuke Mochizuki. et al. Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma. 2020 Nov 05Read more>>
- Satoru Kuriu. et al. Slicing Spheroids in Microfluidic Devices for Morphological and Immunohistochemical Analysis. Micromachines-Basel. 2020 May;11(5):48Read more>>
- Tatiana Hurtado de Mendoza. et al. Tumor-penetrating therapy for 5 integrin-rich pancreas cancer. Nat Commun. 2021 Mar;12(1):1-13Read more>>
- Gehua Zhen. et al. Mechanical stress determines the configuration of TGF activation in articular cartilage. Nat Commun. 2021 Mar;12(1):1-16Read more>>
- Satoru Kuriu. et al. Microfluidic Device Using Mouse Small Intestinal Tissue for the Observation of Fluidic Behavior in the Lumen. Micromachines-Basel. 2021 Jun;12(6):692Read more>>
- Guo Xiaoye. et al. The influence of a modified p53 C-terminal peptide by using a tumor-targeting sequence on cellular apoptosis and tumor treatment. APOPTOSIS. 2023 Dec;:1-17Read more>>
- Yongchang Yang. et al. The CEBPB+ glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth. THERANOSTICS. 2024; 14(10): 41074126Read more>>
- Sidorenko Valeria. et al. Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy. SCI REP-UK. 2024 Jul;14(1):1-16Read more>>
Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-Integrin Alpha V + Beta 5 Polyclonal Antibody, Unconjugated (bs-1356R) at 1:200 followed by conjugation to the secondary antibody and DAB staining.
Formalin-fixed and paraffin embedded cervical cancer labeled with Anti-Integrin αV+β5 Polyclonal Antibody, Unconjugated (bs-1356R) followed by conjugation to the secondary antibody and DAB staining
A549 cells probed with Rabbit Anti-Integrin Alpha V + Beta 5 Polyclonal Antibody (bs-1356R) at 1:100 for 60 minutes at room temperature followed by Goat Anti-Rabbit IgG (H+L) Alexa Fluor 488 Conjugated Secondary.\n
Paraformaldehyde-fixed, paraffin embedded Mouse Kidney; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with Integrin Alpha V + Beta 5 Polyclonal Antibody, Unconjugated (bs-1356R) at 1:400 overnight at 4°C, followed by a conjugated secondary antibody for 20 minutes and DAB staining.
U2-OS cells were fixed with 4% PFA for 10min at room temperature,permeabilized with 0.1% PBST for 20 min at room temperature, and incubated in 5% BSA blocking buffer for 30 min at room temperature. Cells were then stained with Integrin Alpha V + Beta 5 Antibody(bs-1356R)at 1:100 dilution in blocking buffer and incubated for 30 min at room temperature, washed twice with 2%BSA in PBS, followed by secondary antibody incubation for 40 min at room temperature. Acquisitions of 20,000 events were performed. Cells stained with primary antibody (green), and isotype control (orange).